Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HBIO | US
-0.00
-0.45%
Healthcare
Medical Instruments & Supplies
30/06/2024
05/03/2026
0.57
0.59
0.62
0.57
Harvard Bioscience Inc. develops manufactures and sells technologies products and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments amino acid analyzers spectrophotometers and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment including data acquisition systems for cellular analysis complete micro electrode array solutions for in vivo recordings and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research drug discovery and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular central nervous system respiratory and metabolic data; behavioral products; isolated organ and surgical products instruments and accessories for tissue and organ-based lab research including surgical products infusion systems and behavior research systems; turn-key respiratory system solutions including plethysmograph chambers data acquisition hardware physiological signal analysis software and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations websites and distributors to research scientists in pharmaceutical and biotechnology companies universities hospitals and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus DSI Buxco Biochrom BTX Heka Hugo Sachs Multichannel Systems MCS GmbH and Panlab brands. The company was founded in 1901 and is based in Holliston Massachusetts.
View LessValue Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
41.5%1 month
79.7%3 months
68.9%6 months
98.2%-
14.93
1.60
0.62
0.32
163.98
1.44
2.89
3.61M
24.90M
24.90M
-
-7.24
-80.30
-19.70
-14.97
3.05
0.78
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.09
Range1M
0.18
Range3M
0.37
Rel. volume
0.33
Price X volume
90.78K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation | NMTC | Medical Devices | 0.8325 | 25.65M | 5.38% | n/a | 9.63% |
| Myomo Inc | MYO | Medical Devices | 0.84 | 25.39M | 4.39% | n/a | 3.76% |
| Guided Therapeutics Inc | GTHP | Medical Devices | 0.33 | 23.06M | -15.38% | n/a | 0.00% |
| IRIDEX Corporation | IRIX | Medical Devices | 1.38 | 22.96M | -2.13% | n/a | 53.91% |
| JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares | ZJYL | Medical Instruments & Supplies | 0.1448 | 22.67M | -0.75% | 115.00 | 36.89% |
| Milestone Scientific Inc | MLSS | Medical Instruments & Supplies | 0.2849 | 22.02M | -1.42% | n/a | 4.28% |
| Retractable Technologies Inc | RVP | Medical Instruments & Supplies | 0.7 | 20.96M | 2.93% | n/a | 1.63% |
| TELA BIO INC | TELA | Medical Devices | 0.8469 | 20.93M | 0.89% | n/a | 1442.09% |
| Adagio Medical Holdings Inc Common Stock | ADGM | Medical Devices | 0.9699 | 18.93M | -3.01% | n/a | -1038900.00% |
| INBS | INBS | Medical Devices | 4.28 | 18.19M | -2.51% | n/a | 10.46% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Rocky Mountain Chocolate Factory Inc | RMCF | Confectioners | 2.59 | 19.66M | 0.39% | n/a | 46.66% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 3.9 | 5.94M | -2.99% | n/a | 204.46% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 163.98 | - | Expensive |
| Ent. to Revenue | 1.44 | - | Cheaper |
| PE Ratio | - | 47.18 | - |
| Price to Book | 1.60 | 5.71 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 68.91 | - | Riskier |
| Debt to Equity | 0.62 | 0.92 | Cheaper |
| Debt to Assets | 0.32 | 0.27 | Expensive |
| Market Cap | 24.90M | - | Emerging |